These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27089719)

  • 1. [THE EFFECTIVENESS OF THE CORRECTION OF ENDOTHELIAL DYSFUNCTION AND REMODELING OF THE BRACHIAL ARTERY WITH CONCENTRIC AND ECCENTRIC LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH UNSTABLE ANGINA WITH COMORBID HYPERTENSION].
    Denesiuk EV
    Lik Sprava; 2015; (5-6):72-6. PubMed ID: 27089719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [EFFICACY OF STANDARD TWO-YEAR COMPREHENSIVE THERAPY TO ACHIEVE TARGET BLOOD PRESSURE AND REGRESSION DEGREES OF REMODELING OF THE LEFT VENTRICULAR HYPERTROPHY IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION WITH COMORBID HYPERTENSION].
    Denesiuk EV
    Lik Sprava; 2015; (7-8):22-9. PubMed ID: 27491146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].
    Agmadova ZM; Kallaeva AN
    Kardiologiia; 2014; 54(7):9-16. PubMed ID: 25177808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PECULIARITIES OF PHARMACOTHERAPY IN ARTERIAL HYPERTENSION AND COMORBID PATHOLOGY.
    Tofan N; Marish M; Shtanko V
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1092-7. PubMed ID: 26793854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study.
    Roman MJ; Okin PM; Kizer JR; Lee ET; Howard BV; Devereux RB
    J Hypertens; 2010 Feb; 28(2):384-8. PubMed ID: 20051906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients.
    Fabiani I; Pugliese NR; La Carrubba S; Conte L; Antonini-Canterin F; Colonna P; Benedetto F; Calogero E; Barletta V; Carerj S; Buralli S; Taddei S; Romano MF; Di Bello V;
    J Am Soc Hypertens; 2017 Jul; 11(7):412-419. PubMed ID: 28619598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).
    Liljedahl S; Kahan T; Lind L; Arnlöv J
    Echocardiography; 2009 Aug; 26(7):753-8. PubMed ID: 19486119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
    Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mass is related to endothelium-dependent vasodilation in the forearm, but not in the brachial artery, in elderly subjects: the Prospective Investigation of the Vasculature in Uppsala Seniors study.
    Lind L
    J Hum Hypertens; 2008 Nov; 22(11):767-73. PubMed ID: 18548090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.
    Mitsuhashi H; Tamura K; Yamauchi J; Ozawa M; Yanagi M; Dejima T; Wakui H; Masuda S; Azuma K; Kanaoka T; Ohsawa M; Maeda A; Tsurumi-Ikeya Y; Okano Y; Ishigami T; Toya Y; Tokita Y; Ohnishi T; Umemura S
    Atherosclerosis; 2009 Nov; 207(1):186-90. PubMed ID: 19423110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
    Gerdts E; Cramariuc D; de Simone G; Wachtell K; Dahlöf B; Devereux RB
    Eur J Echocardiogr; 2008 Nov; 9(6):809-15. PubMed ID: 18490279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome.
    Tocci G; Figliuzzi I; Presta V; Miceli F; Citoni B; Coluccia R; Musumeci MB; Ferrucci A; Volpe M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):253-259. PubMed ID: 30066227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.